查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1824276

外泌體研究全球市場報告 2025

Exosome Research Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年外泌體研究市場將呈指數級成長，到2029年將達到11,461.9億美元，年複合成長率（CAGR）為31.7%。預測期內的成長可歸因於外泌體療法的臨床應用、液態切片應用的不斷擴展、研究領域產業合作的不斷加強、對細胞外囊泡日益成長的興趣以及對標準化和品管的重視。預測期內的主要趨勢包括臨床應用和治療、分離和分析技術的進步、生物標記的發現和診斷、標準化和品管以及夥伴關係。

未來五年的成長率預測為31.7%，較先前的預測略有下降0.2%。這一下降主要歸因於美國與其他國家之間關稅的影響。貿易摩擦可能會導致韓國和瑞士開發的外泌體分離試劑套件和分析工具的價格上漲，延遲生物標記的發現，並增加研發成本，從而阻礙美國的生物醫學進步。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響也可能產生更廣泛的影響。

外泌體研究市場的預期成長是由慢性疾病的增加所推動的。慢性疾病是指持續時間超過三個月且通常會隨著時間的推移而惡化的疾病。這些包括癌症、心臟病、中風、糖尿病和關節炎等常見疾病。傳染病可以利用感染疾病的釋放來逃避免疫系統的檢測，這凸顯了外泌體研究在理解和對抗各種疾病（包括癌症、神經退化性疾病和發炎性疾病）方面的重要性。例如，美國疾病管制與預防中心於 2022 年 7 月發布的報告顯示，十分之六的美國人患有慢性疾病，十分之四的成年人患有兩種或兩種以上的慢性疾病，例如慢性肺病、心臟病、中風和糖尿病。因此，慢性病盛行率的上升將推動外泌體研究市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球外泌體研究：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球外泌體研究市場：成長率分析
  • 全球外泌體研究市場表現：規模與成長，2019-2024
  • 全球外泌體研究市場預測：規模與成長，2024-2029，2034
  • 全球外泌體研究：總目標市場（TAM）

第6章 市場細分

  • 全球外泌體研究市場：依產品、績效及預測，2019-2024、2024-2029、2034
  • 套件和試劑
  • 裝置
  • 其他
  • 全球外泌體研究市場（依適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 神經退化性疾病
  • 心血管疾病
  • 感染疾病
  • 其他
  • 全球外泌體研究市場的應用、表現及預測（2019-2024、2024-2029、2034）
  • 生物標記
  • 疫苗研發
  • 組織再生
  • 其他
  • 全球外泌體研究市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 學術研究機構
  • 製藥和生物技術公司
  • 醫院和臨床實驗室
  • 全球外泌體研究市場：套件和試劑細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 隔離套件
  • 純化試劑套件
  • 檢測試劑套件
  • 標記試劑
  • 全球外泌體研究市場：儀器細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 超速離心機
  • 流式細胞儀
  • 奈米裝置
  • PCR體系
  • 全球外泌體研究市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 外泌體標準
  • 微流體設備
  • 數據分析軟體

第7章 區域和國家分析

  • 全球外泌體研究市場：依地區、績效及預測，2019-2024、2024-2029、2034
  • 全球外泌體研究市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 外泌體研究市場：競爭格局
  • 外泌體研究市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • System Biosciences LLC
    • QIAGEN NV
    • Exosome Diagnostics Inc.
    • Bio-Techne Corporation

第31章：其他領先和創新企業

  • Hitachi Ltd.
  • Aethlon Medical Inc.
  • NanoSomiX Inc.
  • Malvern Panalytical Ltd.
  • Sistemic Scotland Limited
  • NX PharmaGen Corporation
  • Miltenyi BIoTec GmbH
  • AMS BIoTechnology（Europe）BV
  • Norgen BIoTek Corp.
  • Novus Biologicals LLC
  • Lonza Group AG
  • Sistem-Bio SAS
  • Izon Science Ltd
  • Evomic Science LLC
  • New England Biolabs Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年外泌體研究市場：提供新機會的國家
  • 2029年外泌體研究市場：細分領域帶來新機會
  • 外泌體研究市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24118u

Exosomes, the smallest extracellular vesicles (EVs), hold significant relevance in the tumor microenvironment (TME), where they play a direct role in facilitating angiogenesis, tumor metastasis, and immunosuppression. EVs, which encompass exosomes, can be categorized into three primary groups based on their size, biogenesis, and function.

The primary components of exosome research comprise kits and reagents, as well as instruments and other related tools. Kits and reagents are specialized test kits designed for use in laboratory settings or field environments to detect specific compounds. These kits find applications in various indications such as cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, among others. Additionally, they serve different purposes such as biomarker identification, vaccine development, tissue regeneration, and more. End-users of these products include academic and research institutes, pharmaceutical and biotechnology companies, as well as hospitals and clinical testing laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The exosome research market research report is one of a series of new reports from The Business Research Company that provides exosome research market statistics, including exosome research industry global market size, regional shares, competitors with an exosome research market share, detailed exosome research market segments, market trends and opportunities, and any further data you may need to thrive in the exosome research industry. This exosome research market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome research market size has grown exponentially in recent years. It will grow from $284.9 billion in 2024 to $381.11 billion in 2025 at a compound annual growth rate (CAGR) of 33.8%. The growth in the historic period can be attributed to a growing understanding of exosome biology, increasing investment in life sciences research, the emergence of liquid biopsies, increased focus on personalized medicine, and collaborative research initiatives.

The exosome research market size is expected to see exponential growth in the next few years. It will grow to $1146.19 billion in 2029 at a compound annual growth rate (CAGR) of 31.7%. The growth in the forecast period can be attributed to clinical translation of exosome-based therapeutics, expansion of liquid biopsy applications, increased industry collaboration in research, rising interest in extracellular vesicles, and focus on standardization and quality control. Major trends in the forecast period include clinical applications and therapeutics, technological advancements in isolation and analysis, biomarker discovery and diagnostics, standardization and quality control, collaborations and partnerships.

The forecast of 31.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biomedical advancements by inflating prices of exosome isolation kits and analytical tools developed in South Korea and Switzerland, resulting in slower biomarker discovery and higher research lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the exosome research market is attributed to the increased incidence of chronic medical diseases. Chronic diseases, lasting three months or longer and often worsening over time, include common ailments such as cancer, heart disease, stroke, diabetes, and arthritis. The release of exosomes can be exploited by infections to avoid immune system detection, highlighting the significance of exosome research in understanding and addressing various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. For instance, a report from the Centers for Disease Control and Prevention in July 2022 revealed that 6 out of 10 Americans suffer from chronic diseases, with 4 out of 10 adults experiencing more than two chronic conditions, such as chronic lung disease, heart disease, stroke, and diabetes. Consequently, the increased incidence of chronic medical diseases is set to drive the growth of the exosome research market.

The expected rise in funding for life sciences research is another factor contributing to the growth of the exosome research market. Funding for life sciences research involves financial support provided to scientists, researchers, and organizations for conducting studies in the life sciences field. This increased funding has generated a growing interest in exosome research, particularly in the realms of disease diagnosis and therapeutic applications. The availability of funds has facilitated innovative approaches to exosome research, leveraging advanced technologies and methodologies to explore exosome biology and function. For instance, statistics from the National Center for Science and Engineering in September 2023 indicated a 13.6% increase in federal agency commitments for research and experimental development (R&D) in FY 2021, reaching an all-time high of $190.2 billion (in current dollars) from $167.4 billion in FY 2020. Thus, the rising funding for life sciences research is a driving force behind the growth of the exosome research market.

Product innovations emerge as a prominent trend gaining traction in the exosome research market, with major companies actively introducing inventive products to foster market growth. A case in point is the November 2022 launch by Cell Guidance Systems, a UK-based company, of Instant Exosomes and the LipoQ assay. Instant Exosomes, a subtype of extracellular vesicles (EV), are lipid membrane-enclosed compartments within the 50 to 1,000 nm diameter range. These EVs, released from various cell types and tissues, exhibit highly diverse contents. The LipoQ assay, based on the sulfo-phospo-vanillin method, facilitates the measurement of lipid content, particularly unsaturated fatty acids, within a given sample.

Major players in the exosome research market are strategically focusing on technological innovations, including the development of exosome characterization platforms, to gain a competitive advantage. These platforms encompass a set of tools and techniques dedicated to analyzing the physical, molecular, and functional properties of exosomes. Creative Biolabs Inc., a US-based biotech products and services provider, exemplifies this strategy by launching the Nanosight platform in August 2022. The Nanosight platform, designed specifically for exosome characterization, enhances accessibility and efficiency in exosome research for global researchers. It proves invaluable for researchers exploring the potential applications of exosomes in diverse fields such as medicine, diagnostics, and drug delivery.

In August 2024, BioIVT LLC, a U.S.-based provider of biospecimen solutions, acquired ZenBio Inc. for an undisclosed amount. This acquisition enables BioIVT to strengthen its expertise in cell and tissue models, broadening its range of high-quality biological products for research and drug development. ZenBio Inc., also based in the U.S., is a biotechnology company specializing in human exosome research products.

Major companies operating in the exosome research market include Thermo Fisher Scientific Inc., System Biosciences LLC, QIAGEN N.V., Exosome Diagnostics Inc., Bio-Techne Corporation, Hitachi Ltd., Aethlon Medical Inc., NanoSomiX Inc., Malvern Panalytical Ltd., Sistemic Scotland Limited, NX PharmaGen Corporation, Miltenyi Biotec GmbH, AMS Biotechnology (Europe) B.V., Norgen Biotek Corp., Novus Biologicals LLC, Lonza Group AG, Sistem-Bio S.A.S., Izon Science Ltd, Evomic Science LLC, New England Biolabs Inc., Evox Therapeutics Limited, Codiak BioSciences Inc., MagBio Genomics Inc., Cell Guidance Systems Ltd., Aruna Biomedical PBC, Capricor Therapeutics Inc., Stemcell Technologies Inc., ExoCoBio Inc., Creative Biolabs, Nanovex Biotechnologies S.L.

North America was the largest region in the exosome research market in 2024. The regions covered in the exosome research market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome research market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The exosome research market consists of sales of exosome research tools, exosome isolation and detection tools, exosome marker antibodies, and exosome biomarkers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Research Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome research market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome research ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome research market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Instruments; Other Products
  • 2) By Indication: Cancer; Neurodegenerative Diseases; Cardiovascular Diseases; Infectious Diseases; Other Indications
  • 3) By Application: Biomarkers; Vaccine Development; Tissue Regeneration; Other Applications
  • 4) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinical Testing Laboratories
  • Subsegments:
  • 1) By Kits And Reagents: Isolation Kits; Purification Kits; Detection Kits; Labeling Reagents
  • 2) By Instruments: Ultracentrifuges; Flow Cytometers; Nanosight Instruments; PCR Systems
  • 3) By Other Products: Exosome Standards; Microfluidic Devices; Software For Data Analysis
  • Companies Mentioned: Thermo Fisher Scientific Inc.; System Biosciences LLC; QIAGEN N.V.; Exosome Diagnostics Inc.; Bio-Techne Corporation; Hitachi Ltd.; Aethlon Medical Inc.; NanoSomiX Inc.; Malvern Panalytical Ltd.; Sistemic Scotland Limited; NX PharmaGen Corporation; Miltenyi Biotec GmbH; AMS Biotechnology (Europe) B.V.; Norgen Biotek Corp.; Novus Biologicals LLC; Lonza Group AG; Sistem-Bio S.A.S.; Izon Science Ltd; Evomic Science LLC; New England Biolabs Inc.; Evox Therapeutics Limited; Codiak BioSciences Inc.; MagBio Genomics Inc.; Cell Guidance Systems Ltd.; Aruna Biomedical PBC; Capricor Therapeutics Inc.; Stemcell Technologies Inc.; ExoCoBio Inc.; Creative Biolabs; Nanovex Biotechnologies S.L.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exosome Research Market Characteristics

3. Exosome Research Market Trends And Strategies

4. Exosome Research Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Exosome Research Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Exosome Research PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Exosome Research Market Growth Rate Analysis
  • 5.4. Global Exosome Research Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Exosome Research Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Exosome Research Total Addressable Market (TAM)

6. Exosome Research Market Segmentation

  • 6.1. Global Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Reagents
  • Instruments
  • Other Products
  • 6.2. Global Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Other Indications
  • 6.3. Global Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biomarkers
  • Vaccine Development
  • Tissue Regeneration
  • Other Applications
  • 6.4. Global Exosome Research Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Clinical Testing Laboratories
  • 6.5. Global Exosome Research Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Isolation Kits
  • Purification Kits
  • Detection Kits
  • Labeling Reagents
  • 6.6. Global Exosome Research Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultracentrifuges
  • Flow Cytometers
  • Nanosight Instruments
  • PCR Systems
  • 6.7. Global Exosome Research Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Exosome Standards
  • Microfluidic Devices
  • Software For Data Analysis

7. Exosome Research Market Regional And Country Analysis

  • 7.1. Global Exosome Research Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Exosome Research Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exosome Research Market

  • 8.1. Asia-Pacific Exosome Research Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exosome Research Market

  • 9.1. China Exosome Research Market Overview
  • 9.2. China Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exosome Research Market

  • 10.1. India Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exosome Research Market

  • 11.1. Japan Exosome Research Market Overview
  • 11.2. Japan Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exosome Research Market

  • 12.1. Australia Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exosome Research Market

  • 13.1. Indonesia Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exosome Research Market

  • 14.1. South Korea Exosome Research Market Overview
  • 14.2. South Korea Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exosome Research Market

  • 15.1. Western Europe Exosome Research Market Overview
  • 15.2. Western Europe Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exosome Research Market

  • 16.1. UK Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exosome Research Market

  • 17.1. Germany Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exosome Research Market

  • 18.1. France Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exosome Research Market

  • 19.1. Italy Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exosome Research Market

  • 20.1. Spain Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exosome Research Market

  • 21.1. Eastern Europe Exosome Research Market Overview
  • 21.2. Eastern Europe Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exosome Research Market

  • 22.1. Russia Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exosome Research Market

  • 23.1. North America Exosome Research Market Overview
  • 23.2. North America Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exosome Research Market

  • 24.1. USA Exosome Research Market Overview
  • 24.2. USA Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exosome Research Market

  • 25.1. Canada Exosome Research Market Overview
  • 25.2. Canada Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exosome Research Market

  • 26.1. South America Exosome Research Market Overview
  • 26.2. South America Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exosome Research Market

  • 27.1. Brazil Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exosome Research Market

  • 28.1. Middle East Exosome Research Market Overview
  • 28.2. Middle East Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exosome Research Market

  • 29.1. Africa Exosome Research Market Overview
  • 29.2. Africa Exosome Research Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Exosome Research Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Exosome Research Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exosome Research Market Competitive Landscape And Company Profiles

  • 30.1. Exosome Research Market Competitive Landscape
  • 30.2. Exosome Research Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. System Biosciences LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Exosome Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Exosome Research Market Other Major And Innovative Companies

  • 31.1. Hitachi Ltd.
  • 31.2. Aethlon Medical Inc.
  • 31.3. NanoSomiX Inc.
  • 31.4. Malvern Panalytical Ltd.
  • 31.5. Sistemic Scotland Limited
  • 31.6. NX PharmaGen Corporation
  • 31.7. Miltenyi Biotec GmbH
  • 31.8. AMS Biotechnology (Europe) B.V.
  • 31.9. Norgen Biotek Corp.
  • 31.10. Novus Biologicals LLC
  • 31.11. Lonza Group AG
  • 31.12. Sistem-Bio S.A.S.
  • 31.13. Izon Science Ltd
  • 31.14. Evomic Science LLC
  • 31.15. New England Biolabs Inc.

32. Global Exosome Research Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exosome Research Market

34. Recent Developments In The Exosome Research Market

35. Exosome Research Market High Potential Countries, Segments and Strategies

  • 35.1 Exosome Research Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Exosome Research Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Exosome Research Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer